Market Tracker

09/22 7:58am ET

Northwest Biotherapeutics Inc (NASDAQ:NWBO)

5.45
Data as of Sep 19
 -0.22 / -3.88%
Today’s Change
3.10
Today|||52-Week Range
10.64
+44.56%
Year-to-Date
No recent news for Northwest Biotherapeutics Inc.

Today’s Trading

Previous close5.67
Today’s open5.67
Day’s range-- - --
Volume720,575
Average volume (3 months)652,188
Market cap$324.3M
Dividend yield--
Data as of 09/19/2014

Growth & Valuation

Earnings growth (last year)+65.03%
Earnings growth (this year)+8.50%
Earnings growth (next 5 years)+10.00%
Revenue growth (last year)+4.79%
P/E ratioNM
Price/Sales153.15
Price/Book--

Competitors

 Today’s
change
Today’s
% change
XNPTXenoport Inc+0.03+0.56%
PETXAratana Therapeutics...-0.03-0.30%
ACRXAcelRx Pharmaceutica...-0.22-3.08%
PRQRProQR Therapeutics B...+1.64+11.13%
Data as of 09/19/2014

Financials

Next reporting dateNovember 14, 2014
EPS forecast (this quarter)-$0.33
Annual revenue (last year)$809.0K
Annual profit (last year)-$65.8M
Net profit margin-8,132.14%

Profile

Sector
Health Technology
Industry
Biotechnology
Chairman, President, CEO, CFO &
CAO
Linda F. Powers
Chief Scientific Officer, Secretary &
Director
Alton L. Boynton
Corporate headquarters
Bethesda, Maryland

Forecasts